Specifically, JQ1 synergized with CDK2 inhibitor Milciclib which has been used in clinical trials to induce apoptosis and inhibit MYCN amplified NB cell growth by downregulating the MYC target genes (Bolin et al., 2018). Here, MYC is linked to neuroblastoma.